2021 Volume 36 Issue 1 Pages 82-88
Surgical resection is only the potential cure for patients with pancreatic cancer and is also associated with serious complications. In recent years, the use of novel chemotherapy and radiotherapy approaches has improved survival in patients with locally advanced pancreatic cancer. Evidence regarding the efficacy of extended pancreatectomy has become more important. Vein resection is justified with limited indications. Arterial resection has not been shown to be beneficial, and distal pancreatectomy with celiac axis resection may be useful in certain (neo) adjuvant settings. The benefit of extended lymphadenectomy has not been shown, and benefits of standard lymphadenectomy remain unclear. The prognosis of patients with para-aortic lymph node metastases needs further evaluation.
